Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertriglyceridemia: HELP
Terry A. Jacobson
Based on 7 articles published since 2010
(Why 7 articles?)
||||
Expertise Level
The expertise of Terry A. Jacobson ranks in the
  • Top 0.33%
  • ... of 13,274 published authors worldwide on Hypertriglyceridemia
  • ... from 2010 through 2020
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Emory University   Contact    
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA, USA. · Pubmed 22894624
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Terry A. Jacobson in 2010-2020 about Hypertriglyceridemia:

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. 2019
  • Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. 2019
  • Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. 2014
  • A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial. 2012
  • Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. 2012
  • Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia. 2012
  • Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. 2011
Show List of Full Article Records
Google Searches

Learn more about Terry A. Jacobson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Emory University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Emory University
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA, USA. · Pubmed 22894624
4 Other Locations Show
Yearly article counts 02000010310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.